51 related articles for article (PubMed ID: 17192687)
1. Expression of cyclooxygenase-2 and 12-lipoxygenase in human breast cancer and their relationship with HER-2/neu and hormonal receptors: impact on prognosis and therapy.
Mohammad AM; Abdel HA; Abdel W; Ahmed AM; Wael T; Eiman G
Indian J Cancer; 2006; 43(4):163-8. PubMed ID: 17192687
[TBL] [Abstract][Full Text] [Related]
2. Comparison of hormonal receptor and HER-2 status between breast primary tumours and relapsing tumours: clinical implications of progesterone receptor loss.
Bogina G; Bortesi L; Marconi M; Venturini M; Lunardi G; Coati F; Massocco A; Manfrin E; Pegoraro C; Zamboni G
Virchows Arch; 2011 Jul; 459(1):1-10. PubMed ID: 21643691
[TBL] [Abstract][Full Text] [Related]
3. Estrogen- and progesterone-receptor status in ECOG 2197: comparison of immunohistochemistry by local and central laboratories and quantitative reverse transcription polymerase chain reaction by central laboratory.
Badve SS; Baehner FL; Gray RP; Childs BH; Maddala T; Liu ML; Rowley SC; Shak S; Perez EA; Shulman LJ; Martino S; Davidson NE; Sledge GW; Goldstein LJ; Sparano JA
J Clin Oncol; 2008 May; 26(15):2473-81. PubMed ID: 18487567
[TBL] [Abstract][Full Text] [Related]
4. Local expression of complement factor I in breast cancer cells correlates with poor survival and recurrence.
Okroj M; Holmquist E; Nilsson E; Anagnostaki L; Jirström K; Blom AM
Cancer Immunol Immunother; 2015 Apr; 64(4):467-78. PubMed ID: 25618258
[TBL] [Abstract][Full Text] [Related]
5. Stromal cell expression of caveolin-1 predicts outcome in breast cancer.
Sloan EK; Ciocca DR; Pouliot N; Natoli A; Restall C; Henderson MA; Fanelli MA; Cuello-Carrión FD; Gago FE; Anderson RL
Am J Pathol; 2009 Jun; 174(6):2035-43. PubMed ID: 19411449
[TBL] [Abstract][Full Text] [Related]
6. RNA-binding protein CUGBP1 controls the differential INSR splicing in molecular subtypes of breast cancer cells and affects cell aggressiveness.
Huang G; Song C; Wang N; Qin T; Sui S; Obr A; Zeng L; Wood TL; Leroith D; Li M; Wu Y
Carcinogenesis; 2020 Sep; 41(9):1294-1305. PubMed ID: 31958132
[TBL] [Abstract][Full Text] [Related]
7. A Joint Bayesian Model for Integrating Microarray and RNA Sequencing Transcriptomic Data.
Ma T; Liang F; Oesterreich S; Tseng GC
J Comput Biol; 2017 Jul; 24(7):647-662. PubMed ID: 28541721
[TBL] [Abstract][Full Text] [Related]
8. Beta class II tubulin predominates in normal and tumor breast tissues.
Dozier JH; Hiser L; Davis JA; Thomas NS; Tucci MA; Benghuzzi HA; Frankfurter A; Correia JJ; Lobert S
Breast Cancer Res; 2003; 5(5):R157-69. PubMed ID: 12927047
[TBL] [Abstract][Full Text] [Related]
9. Unveiling the Role of Hormonal Imbalance in Breast Cancer Development: A Comprehensive Review.
Satpathi S; Gaurkar SS; Potdukhe A; Wanjari MB
Cureus; 2023 Jul; 15(7):e41737. PubMed ID: 37575755
[TBL] [Abstract][Full Text] [Related]
10. Understanding the Link between Sugar and Cancer: An Examination of the Preclinical and Clinical Evidence.
Epner M; Yang P; Wagner RW; Cohen L
Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551528
[TBL] [Abstract][Full Text] [Related]
11. Cross-Talk between Cancer Cells and the Tumour Microenvironment: The Role of the 5-Lipoxygenase Pathway.
Moore GY; Pidgeon GP
Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28125014
[TBL] [Abstract][Full Text] [Related]
12. A Sucrose-Enriched Diet Promotes Tumorigenesis in Mammary Gland in Part through the 12-Lipoxygenase Pathway.
Jiang Y; Pan Y; Rhea PR; Tan L; Gagea M; Cohen L; Fischer SM; Yang P
Cancer Res; 2016 Jan; 76(1):24-9. PubMed ID: 26729790
[TBL] [Abstract][Full Text] [Related]
13. The polymorphism (Gln261Arg) of 12-lipoxygenase and cancer risk: a meta-analysis.
Shan D; Shen K; Zhu J; Feng M; Wu Y; Wan C; Shen Y; Xu L
Int J Clin Exp Med; 2015; 8(1):488-95. PubMed ID: 25785021
[TBL] [Abstract][Full Text] [Related]
14. Associations between ALOX, COX, and CRP polymorphisms and breast cancer among Hispanic and non-Hispanic white women: The breast cancer health disparities study.
Connor AE; Baumgartner RN; Baumgartner KB; Pinkston CM; Boone SD; John EM; Torres-Mejía G; Hines LM; Giuliano AR; Wolff RK; Slattery ML
Mol Carcinog; 2015 Dec; 54(12):1541-53. PubMed ID: 25339205
[TBL] [Abstract][Full Text] [Related]
15. Receptor-defined subtypes of breast cancer in indigenous populations in Africa: a systematic review and meta-analysis.
Eng A; McCormack V; dos-Santos-Silva I
PLoS Med; 2014 Sep; 11(9):e1001720. PubMed ID: 25202974
[TBL] [Abstract][Full Text] [Related]
16. The concentration of 12-lipoxygenase in platelet rich plasma as an indication of cancer of the prostate.
Piotrowska M; Szefel J; Skrzypczak-Jankun E; Lysiak-Szydłowska W; Szajewski M; Aleksandrowicz-Wrona E; Jankun J
Contemp Oncol (Pozn); 2013; 17(4):389-93. PubMed ID: 24592128
[TBL] [Abstract][Full Text] [Related]
17. The obesity-inflammation-eicosanoid axis in breast cancer.
Vona-Davis L; Rose DP
J Mammary Gland Biol Neoplasia; 2013 Dec; 18(3-4):291-307. PubMed ID: 24170420
[TBL] [Abstract][Full Text] [Related]
18. Fatty acid metabolites in rapidly proliferating breast cancer.
O'Flaherty JT; Wooten RE; Samuel MP; Thomas MJ; Levine EA; Case LD; Akman SA; Edwards IJ
PLoS One; 2013; 8(5):e63076. PubMed ID: 23658799
[TBL] [Abstract][Full Text] [Related]
19. Association of a functional polymorphism (Gln261Arg) in 12-lipoxygenase with breast cancer.
Prasad VV; Kolli P; Moganti D
Exp Ther Med; 2011 Mar; 2(2):317-323. PubMed ID: 22977504
[TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of cyclooxygenase-2 and matrix metalloproteinases (MMP-2 and MT1-MMP) in human breast cancer tissue.
Mohammad MA; Zeeneldin AA; Abd Elmageed ZY; Khalil EH; Mahdy SM; Sharada HM; Sharawy SK; Abdel-Wahab AH
Mol Cell Biochem; 2012 Jul; 366(1-2):269-75. PubMed ID: 22527932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
